XML 20 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated statement of changes in shareholders' equity - USD ($)
$ in Millions
Shareholders' equity - Group share
Common shares issued
Paid-in surplus and retained earnings
Currency translation adjustment
Treasury shares
Non-controlling interests
Total
Equity as of the beginning of the period at Dec. 31, 2016 $ 98,680 $ 7,604 $ 105,547 $ (13,871) $ (600) $ 2,894 $ 101,574
Common shares issued as of the beginning of the period at Dec. 31, 2016   2,430,365,862     (10,587,822)    
Net income 4,886   4,886     (80) 4,806
Other comprehensive income 3,695   138 3,557   18 3,713
Comprehensive income 8,581   5,024 3,557   (62) 8,519
Dividend (3,297)   (3,297)     (76) (3,373)
Issuance of common shares 3,296 $ 193 3,103       3,296
Issuance of common shares (in shares)   71,170,026          
Sale of treasury shares (in shares) [1]         4,000    
Share-based payments 74   74       74
Payments on perpetual subordinated notes (142)   (142)       (142)
Other operations with non-controlling interests (7)   (7)     7  
Other items 3   3     9 12
Equity as of the end of the period at Jun. 30, 2017 107,188 $ 7,797 110,305 (10,314) $ (600) 2,772 109,960
Common shares issued as of the end of the period at Jun. 30, 2017   2,501,535,888     (10,583,822)    
Net income 3,745   3,745     (252) 3,493
Other comprehensive income 2,986   580 2,406   26 3,012
Comprehensive income 6,731   4,325 2,406   (226) 6,505
Dividend (3,695)   (3,695)     (65) (3,760)
Issuance of common shares 1,413 $ 85 1,328       1,413
Issuance of common shares (in shares)   27,453,728          
Sale of treasury shares [1]     (142)   $ 142    
Sale of treasury shares (in shares) [1]         2,207,066    
Share-based payments 77   77       77
Payments on perpetual subordinated notes (160)   (160)       (160)
Other operations with non-controlling interests (1)   (1)     (3) (4)
Other items 3   3     3 6
Equity as of the end of the period at Dec. 31, 2017 111,556 $ 7,882 112,040 (7,908) $ (458) 2,481 114,037
Common shares issued as of the end of the period at Dec. 31, 2017   2,528,989,616     (8,376,756)    
Net income             2,649
Other comprehensive income             1,736
Comprehensive income             4,385
Equity as of the end of the period at Mar. 31, 2018             123,686
Equity as of the beginning of the period at Dec. 31, 2017 111,556 $ 7,882 112,040 (7,908) $ (458) 2,481 114,037
Common shares issued as of the beginning of the period at Dec. 31, 2017   2,528,989,616     (8,376,756)    
Net income 6,357   6,357     (74) 6,283
Other comprehensive income (1,551)   305 (1,856)   (38) (1,589)
Comprehensive income 4,806   6,662 (1,856)   (112) 4,694
Dividend (4,070)   (4,070)     (84) (4,154)
Issuance of common shares 7,693 $ 423 7,270       7,693
Issuance of common shares (in shares)   136,887,716          
Purchase of treasury shares (2,004)       $ (2,004)   (2,004)
Purchase of treasury shares (in shares)         (33,056,514)    
Sale of treasury shares (in shares) [1]         3,450    
Share-based payments 192   192       192
Payments on perpetual subordinated notes (161)   (161)       (161)
Other operations with non-controlling interests (4)   (4)     4  
Other items (33)   (33)     (1) (34)
Equity as of the end of the period at Jun. 30, 2018 117,975 $ 8,305 121,896 (9,764) $ (2,462) 2,288 120,263
Common shares issued as of the end of the period at Jun. 30, 2018   2,665,877,332     (41,429,820)    
Equity as of the beginning of the period at Mar. 31, 2018             123,686
Net income             3,634
Other comprehensive income             (3,325)
Comprehensive income             309
Equity as of the end of the period at Jun. 30, 2018 $ 117,975 $ 8,305 $ 121,896 $ (9,764) $ (2,462) $ 2,288 $ 120,263
Common shares issued as of the end of the period at Jun. 30, 2018   2,665,877,332     (41,429,820)    
[1] Treasury shares related to the restricted stock grants.